PortfoliosLab logoPortfoliosLab logo
Laboratory Corporation of America Holdings (LH)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US50540R4092
CUSIP
50540R409
IPO Date
Mar 29, 1990

Highlights

Market Cap
$22.20B
Enterprise Value
$28.89B
EPS (TTM)
$10.48
PE Ratio
25.47
Total Revenue (TTM)
$13.95B
Gross Profit (TTM)
$4.01B
EBITDA (TTM)
$1.86B
Year Range
$209.38 - $293.72
Target Price
$315.71
ROA (TTM)
4.77%
ROE (TTM)
10.17%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Laboratory Corporation of America Holdings, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Laboratory Corporation of America Holdings (LH) has returned 6.62% so far this year and 15.87% over the past 12 months. Over the last ten years, LH has returned 10.65% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.


Laboratory Corporation of America Holdings

1D
1.21%
1M
-7.72%
YTD
6.62%
6M
-6.57%
1Y
15.87%
3Y*
11.98%
5Y*
5.22%
10Y*
10.65%

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Mar 29, 1990, LH's average daily return is +0.06%, while the average monthly return is +1.06%. At this rate, your investment would double in approximately 5.5 years.

Historically, 57% of months were positive and 43% were negative. The best month was Sep 1998 with a return of +44.4%, while the worst month was Aug 1998 at -47.1%. The longest winning streak lasted 12 consecutive months, and the longest losing streak was 5 months.

On a daily basis, LH closed higher 48% of trading days. The best single day was Sep 1, 1998 with a return of +27.8%, while the worst single day was Aug 2, 1996 at -35.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20268.23%6.75%-7.72%6.62%
20258.93%0.78%-7.29%3.55%3.60%5.44%-0.93%7.16%3.26%-11.53%6.12%-6.66%10.62%
2024-2.20%-2.59%1.22%-7.82%-2.85%4.41%5.86%7.04%-2.79%2.14%5.96%-4.91%2.22%
20237.07%-4.78%-4.15%-1.18%-5.94%13.55%3.18%-2.40%-3.39%-0.66%8.98%4.79%13.82%
2022-13.64%-0.04%-2.80%-8.87%2.98%-5.01%11.87%-13.84%-9.08%8.32%8.81%-2.17%-24.41%
202112.46%4.81%6.30%4.25%3.24%0.50%7.36%2.44%-7.23%1.98%-0.59%10.12%54.37%

Benchmark Metrics

Laboratory Corporation of America Holdings has an annualized alpha of 7.65%, beta of 0.72, and R² of 0.11 versus S&P 500 Index. Calculated based on daily prices since March 30, 1990.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (57.15%) than losses (56.36%) — typical of diversified or defensive assets.
  • R² of 0.11 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
7.65%
Beta
0.72
0.11
Upside Capture
57.15%
Downside Capture
56.36%

Return for Risk

Risk / Return Rank

LH ranks 61 for risk / return — better than 61% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


LH Risk / Return Rank: 6161
Overall Rank
LH Sharpe Ratio Rank: 6363
Sharpe Ratio Rank
LH Sortino Ratio Rank: 5656
Sortino Ratio Rank
LH Omega Ratio Rank: 5454
Omega Ratio Rank
LH Calmar Ratio Rank: 6565
Calmar Ratio Rank
LH Martin Ratio Rank: 6565
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Laboratory Corporation of America Holdings (LH) and compare them to a chosen benchmark (S&P 500 Index).


LHBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.63

0.90

-0.26

Sortino ratio

Return per unit of downside risk

1.04

1.39

-0.34

Omega ratio

Gain probability vs. loss probability

1.13

1.21

-0.08

Calmar ratio

Return relative to maximum drawdown

1.13

1.40

-0.27

Martin ratio

Return relative to average drawdown

2.73

6.61

-3.88

Explore LH risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History

Laboratory Corporation of America Holdings provided a 1.08% dividend yield over the last twelve months, with an annual payout of $2.88 per share. The company has been increasing its dividends for 3 consecutive years.


0.90%1.00%1.10%1.20%1.30%$0.00$0.50$1.00$1.50$2.00$2.50$3.002022202320242025
Dividends
Dividend Yield
PeriodTTM2025202420232022
Dividend$2.88$2.88$2.88$2.68$1.86

Dividend yield

1.08%1.15%1.26%1.18%0.92%

Monthly Dividends

The table displays the monthly dividend distributions for Laboratory Corporation of America Holdings. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.72$0.00$0.72
2025$0.00$0.72$0.00$0.00$0.72$0.00$0.00$0.72$0.00$0.00$0.72$0.00$2.88
2024$0.00$0.72$0.00$0.00$0.72$0.00$0.00$0.72$0.00$0.00$0.72$0.00$2.88
2023$0.00$0.62$0.00$0.00$0.62$0.00$0.00$0.72$0.00$0.00$0.72$0.00$2.68
2022$0.62$0.00$0.00$0.62$0.00$0.00$0.62$0.00$1.86

Dividend Yield & Payout


Dividend Yield

Laboratory Corporation of America Holdings has a dividend yield of 1.08%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.

Payout Ratio

Laboratory Corporation of America Holdings has a payout ratio of 27.46%, which is quite average when compared to the overall market. This suggests that Laboratory Corporation of America Holdings strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Laboratory Corporation of America Holdings. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Laboratory Corporation of America Holdings was 96.15%, occurring on Aug 31, 1998. Recovery took 2089 trading sessions.

The current Laboratory Corporation of America Holdings drawdown is 7.81%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.15%Dec 31, 19911686Aug 31, 19982089Dec 19, 20063775
-46.58%Feb 18, 202025Mar 23, 202082Jul 20, 2020107
-44.7%Jul 23, 1990117Jan 7, 199154Mar 25, 1991171
-36.21%Jun 18, 2018132Dec 24, 2018286Feb 13, 2020418
-34.61%Jan 3, 2022195Oct 11, 2022667Jun 10, 2025862

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Laboratory Corporation of America Holdings over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Laboratory Corporation of America Holdings is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for LH, comparing it with other companies in the Diagnostics & Research industry. Currently, LH has a P/E ratio of 25.5. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for LH relative to other companies in the Diagnostics & Research industry. Currently, LH has a P/S ratio of 1.6. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for LH in comparison with other companies in the Diagnostics & Research industry. Currently, LH has a P/B value of 2.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items